Fresenius SE & Co. KGaA (BIT:1FRE)

Market Cap	26.78B
Revenue (ttm)	22.45B
Net Income (ttm)	1.14B
Shares Out	n/a
EPS (ttm)	2.03
PE Ratio	23.43
Forward PE	12.97
Dividend	1.00 (2.12%)
Ex-Dividend Date	May 26, 2025

Volume	n/a
Average Volume	142
Open	n/a
Previous Close	47.23
Day's Range	n/a
52-Week Range	31.90 - 50.60
Beta	n/a
RSI	51.66
Earnings Date	Mar 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1912
• Employees: 176,486
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1FRE